Sort
15,842 grants matching “pancreatic cancer”
CORE F: FUNCTIONAL GENOMICS FACILITY
$162,787Brian Keith Dieckgraefe · Washington University · P30 · FY2007 · DK
Nanocage System for Endoscopic Imaging and Staging of Pancreatic Cancer
$162,761Stanislav Y Emelianov · University Of Texas At Austin · R21 · FY2010 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$162,720Dai Fukumura · Massachusetts General Hospital · R01 · FY2017 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$162,720Dai Fukumura · Massachusetts General Hospital · R01 · FY2018 · CA
Core B: Biological Models, Biostatistics, Molecular Pathology and Microscopy
$162,637Brett E Bouma · Massachusetts General Hospital · P01 · FY2015 · CA
Smad4 Stability by beta-TrCP1 in Pancreatic Cancer
$162,610University Of Alabama At Birmingham · R21 · FY2004 · CA
MR-Guided Precision Thermal Therapy of Retroperitoneal Tumors
$162,583Frank Graham Sommer · Stanford University · P01 · FY2013 · CA
The Role of SHIP-1 in the Modulation of Immunoregulatory Cells in Pancreatic Canc
$162,581Tomar Ghansah · University Of South Florida · R21 · FY2015 · CA
Mouse Model of Pancreatic Cancer Progression-Maintenance
$162,540Nabeel Bardeesy · Massachusetts General Hospital · K01 · FY2009 · CA
GPCR regulation of progenitor cells in pancreatic cancer
$162,538Rolf A Brekken · Ut Southwestern Medical Center · R21 · FY2013 · CA
Characterization of polyamine biosynthetic enzymes from human gut microbes associated with colon and pancreatic cancer
$162,500Jeffrey S McFarlane · Fort Lewis College · R16 · FY2022 · GM
Characterization of polyamine biosynthetic enzymes from human gut microbes associated with colon and pancreatic cancer
$162,500Jeffrey S McFarlane · Fort Lewis College · R16 · FY2024 · GM
Characterization of polyamine biosynthetic enzymes from human gut microbes associated with colon and pancreatic cancer
$162,500Jeffrey S McFarlane · Fort Lewis College · R16 · FY2023 · GM
Characterization of polyamine biosynthetic enzymes from human gut microbes associated with colon and pancreatic cancer
$162,500Jeffrey S McFarlane · Fort Lewis College · R16 · FY2025 · GM
Columbia-GHI Consortium for Claims-Based Cancer Studies
$162,462Steven D Stellman · Columbia University Health Sciences · R21 · FY2007 · CA
CD40 Pathway in Pancreatic Adenocarcinoma
$162,462Gregory L Beatty · University Of Pennsylvania · K08 · FY2014 · CA
CD40 Pathway in Pancreatic Adenocarcinoma
$162,462Gregory L Beatty · University Of Pennsylvania · K08 · FY2011 · CA
CD40 Pathway in Pancreatic Adenocarcinoma
$162,462Gregory L Beatty · University Of Pennsylvania · K08 · FY2013 · CA
CD40 Pathway in Pancreatic Adenocarcinoma
$162,462Gregory L Beatty · University Of Pennsylvania · K08 · FY2012 · CA
CD40 Pathway in Pancreatic Adenocarcinoma
$162,462Gregory L Beatty · University Of Pennsylvania · K08 · FY2015 · CA
Role of the BMP SMADs in Oncogenesis
$162,369Stephanie A Pangas · Baylor College Of Medicine · R01 · FY2010 · CA
TARGETED DELIVERY OF GENES TO ANGIOGENIC VASCULATURE
$162,336University Of Texas Md Anderson Can Ctr · R01 · FY2000 · CA
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer
$162,333Robert H Vonderheide · University Of Pennsylvania · R01 · FY2021 · CA
Cancer Epidemiology
$162,194Peter A Kanetsky · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2022 · CA
Lysosome Dynamics-Regulated Lipid Metabolism in Pancreatic Cancer
$162,143Jing Pu · University Of New Mexico Health Scis Ctr · P20 · FY2019 · GM